免疫疗法：癌症疫苗引发抗病毒类防御反应。 - Suppr

Immunotherapy: Cancer vaccine triggers antiviral-type defences.

作者信息

De Vries Jolanda, Figdor Carl

机构信息

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands.

出版信息

Nature. 2016 Jun 16;534(7607):329-31. doi: 10.1038/nature18443. Epub 2016 Jun 1.

DOI:10.1038/nature18443

PMID:27281206

Abstract

摘要

相似文献

Immunotherapy: Cancer vaccine triggers antiviral-type defences.

Nature. 2016 Jun 16;534(7607):329-31. doi: 10.1038/nature18443. Epub 2016 Jun 1.

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.

Nature. 2016 Jun 16;534(7607):396-401. doi: 10.1038/nature18300. Epub 2016 Jun 1.

Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.

J Immunother. 2012 Oct;35(8):641-9. doi: 10.1097/CJI.0b013e31826f79c8.

Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.

Methods Mol Biol. 2010;629:405-52. doi: 10.1007/978-1-60761-657-3_27.

DC therapy for metastatic melanoma.

Cytotherapy. 2004;6(2):148-53. doi: 10.1080/14653240410005627.

[Dendritic cells--a new weapon in therapy of melanoma?].

Hautarzt. 1996 Jun;47(6):488-90.

[Vaccinal cell therapy in melanoma].

Bull Cancer. 2003 Aug-Sep;90(8-9):722-33.

Intralesional Cancer Immunotherapies.

Hematol Oncol Clin North Am. 2019 Apr;33(2):249-260. doi: 10.1016/j.hoc.2018.12.009. Epub 2019 Jan 28.

Immunotherapy for melanoma.

Clin Dermatol. 2004 May-Jun;22(3):251-65. doi: 10.1016/j.clindermatol.2003.12.001.

Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides.

Jpn J Clin Oncol. 2007 Feb;37(2):140-5. doi: 10.1093/jjco/hyl136. Epub 2007 Jan 25.

引用本文的文献

Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy.

Pharmaceuticals (Basel). 2025 May 19;18(5):746. doi: 10.3390/ph18050746.

Nanodiamonds Interact with Primary Human Macrophages and Dendritic Cells Evoking a Vigorous Interferon Response.

ACS Nano. 2025 May 27;19(20):19057-19079. doi: 10.1021/acsnano.4c18108. Epub 2025 May 14.

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

Nat Med. 2025 Jan;31(1):152-164. doi: 10.1038/s41591-024-03334-7. Epub 2025 Jan 6.

Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses.

Nat Biomed Eng. 2024 Jun;8(6):726-739. doi: 10.1038/s41551-023-01083-5. Epub 2023 Aug 24.

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects.

Front Oncol. 2023 Jul 6;13:1168454. doi: 10.3389/fonc.2023.1168454. eCollection 2023.

Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles.

J Funct Biomater. 2023 Feb 28;14(3):136. doi: 10.3390/jfb14030136.

Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists.

Pharmaceutics. 2021 Aug 31;13(9):1374. doi: 10.3390/pharmaceutics13091374.

Emerging glyco-based strategies to steer immune responses.

FEBS J. 2021 Aug;288(16):4746-4772. doi: 10.1111/febs.15830. Epub 2021 May 15.

Cancer immunoediting: A game theoretical approach.

In Silico Biol. 2021;14(1-2):1-12. doi: 10.3233/ISB-200475.

Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo.

MAbs. 2020 Jan-Dec;12(1):1834818. doi: 10.1080/19420862.2020.1834818.

本文引用的文献

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.

Nature. 2016 Jun 16;534(7607):396-401. doi: 10.1038/nature18300. Epub 2016 Jun 1.

T cell exclusion, immune privilege, and the tumor microenvironment.

Science. 2015 Apr 3;348(6230):74-80. doi: 10.1126/science.aaa6204.

Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.

Cancer Res. 2013 Feb 1;73(3):1063-75. doi: 10.1158/0008-5472.CAN-12-2583. Epub 2013 Jan 23.

Cancer immunotherapy via dendritic cells.

Nat Rev Cancer. 2012 Mar 22;12(4):265-77. doi: 10.1038/nrc3258.

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.

Gene Ther. 2010 Aug;17(8):961-71. doi: 10.1038/gt.2010.52. Epub 2010 Apr 22.

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.

J Control Release. 2010 Jun 1;144(2):118-26. doi: 10.1016/j.jconrel.2010.02.013. Epub 2010 Feb 13.

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Nat Rev Immunol. 2007 Oct;7(10):790-802. doi: 10.1038/nri2173.

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

Blood. 2005 Aug 15;106(4):1278-85. doi: 10.1182/blood-2005-01-0318. Epub 2005 May 5.

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.

J Exp Med. 2004 Mar 15;199(6):815-24. doi: 10.1084/jem.20032220.

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.

J Exp Med. 2002 Dec 16;196(12):1627-38. doi: 10.1084/jem.20021598.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immunotherapy: Cancer vaccine triggers antiviral-type defences.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献